A study in the Lancet indicates that using the drug on Covid-19 patients could increase their likelihood of dying.
The World Health Organisation said on Monday it had "temporarily" suspended clinical trials of hydroxychloriquine as a potential treatment for Covid-19 being carried out across a range of countries as a precautionary measure.

The decision came after the publication last week of a study in the Lancet indicating that using the drug on Covid-19 patients could increase their likelihood of dying, WHO chief Tedros Adhanom Ghebreyesus told a virtual press conference.

Tedros said that the executive group of the so-called Solidarity Trial, in which hundreds of hospitals across several countries have enrolled patients to test several possible treatments for the novel coronavirus, had as a precaution suspended trials using that drug.

SOURCE : KHALEEJTIMES